Director at Ingevity (NYSE: NGVT) granted 1,904 RSUs

Q: How many restricted stock units did Frederick J. Lynch receive from Ingevity (NGVT)?

He received 1,904 restricted stock units of Ingevity common stock. These units represent a stock-based compensation award and will convert into shares upon vesting, aligning the director’s interests with shareholders over the specified vesting period defined in the incentive plan.

Q: When do Frederick J. Lynch’s Ingevity (NGVT) restricted stock units vest?

The restricted stock units will vest in full on April 30, 2027 . Vesting means the units convert into shares of common stock on that date, assuming applicable conditions are satisfied, thereby increasing Lynch’s fully vested equity ownership in the company at that time.

Q: Was Frederick J. Lynch’s Ingevity (NGVT) equity award an open-market stock purchase?

No, the filing shows a grant of restricted stock units with a per-share price of $0.00. This indicates an equity compensation award under the company’s incentive plan, not a cash-funded open-market transaction where the director bought shares on a public exchange.

Q: How many Ingevity (NGVT) shares does Frederick J. Lynch hold after this grant?

After the reported grant, Lynch’s direct holdings total 28,263 shares of Ingevity common stock. This figure reflects his position following the award and helps investors understand the scale of his equity stake relative to the new restricted stock unit grant.

Q: Under which plan were Frederick J. Lynch’s Ingevity (NGVT) restricted stock units granted?

The restricted stock units were granted under Ingevity Corporation’s 2025 Omnibus Incentive Plan . This plan governs stock-based compensation awards, such as RSUs, granted to eligible participants, including directors, to align their long-term incentives with shareholder interests.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Lynch Frederick J reported acquisition or exercise transactions in this Form 4 filing.

Ingevity Corp director Frederick J. Lynch reported a compensation-related equity award. He received 1,904 restricted stock units of Ingevity common stock at no purchase price under the company’s 2025 Omnibus Incentive Plan. These units will vest in full on April 30, 2027, bringing his direct holdings to 28,263 shares after the grant.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lynch Frederick J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,904	$0.00	--

Holdings After Transaction: Common Stock — 28,263 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant: 1,904 units Post-grant holdings: 28,263 shares Vesting date: April 30, 2027 +1 more

4 metrics

RSU grant 1,904 units Restricted stock units granted under 2025 Omnibus Incentive Plan

Post-grant holdings 28,263 shares Total common stock held directly after the award

Vesting date April 30, 2027 Date when all granted RSUs vest in full

Grant price $0.00 per unit Indicates compensation grant, not open-market purchase

Key Terms

restricted stock units, 2025 Omnibus Incentive Plan, Form 4

3 terms

restricted stock units financial

"Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Incentive Plan financial

"pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/01/2026 - 06:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lynch Frederick J

(Last)

(First)

(Middle)

4920 O'HEAR AVE

SUITE 400

(Street)

NORTH CHARLESTON

SOUTH CAROLINA

29405

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		A		1,904⁽¹⁾	A	$0	28,263	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.

Remarks:

	Frederick J. Lynch By: Mavis G. Huger as Attorney-in-Fact	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Frederick J. Lynch report in his latest Form 4 for Ingevity (NGVT)?

Frederick J. Lynch reported receiving a grant of restricted stock units in Ingevity common stock. The award is part of Ingevity Corporation’s 2025 Omnibus Incentive Plan, reflecting equity-based compensation rather than an open-market stock purchase or sale by the director.

How many restricted stock units did Frederick J. Lynch receive from Ingevity (NGVT)?

He received 1,904 restricted stock units of Ingevity common stock. These units represent a stock-based compensation award and will convert into shares upon vesting, aligning the director’s interests with shareholders over the specified vesting period defined in the incentive plan.

When do Frederick J. Lynch’s Ingevity (NGVT) restricted stock units vest?

The restricted stock units will vest in full on April 30, 2027. Vesting means the units convert into shares of common stock on that date, assuming applicable conditions are satisfied, thereby increasing Lynch’s fully vested equity ownership in the company at that time.

Was Frederick J. Lynch’s Ingevity (NGVT) equity award an open-market stock purchase?

No, the filing shows a grant of restricted stock units with a per-share price of $0.00. This indicates an equity compensation award under the company’s incentive plan, not a cash-funded open-market transaction where the director bought shares on a public exchange.

How many Ingevity (NGVT) shares does Frederick J. Lynch hold after this grant?

After the reported grant, Lynch’s direct holdings total 28,263 shares of Ingevity common stock. This figure reflects his position following the award and helps investors understand the scale of his equity stake relative to the new restricted stock unit grant.

Under which plan were Frederick J. Lynch’s Ingevity (NGVT) restricted stock units granted?

The restricted stock units were granted under Ingevity Corporation’s 2025 Omnibus Incentive Plan. This plan governs stock-based compensation awards, such as RSUs, granted to eligible participants, including directors, to align their long-term incentives with shareholder interests.